The Third Scientific
Meeting of The TMJ Association
Advancing Diagnostic
Approaches for TMJ Diseases/Disorders
MEETING EVENTS
TMJ Patient Meeting
Hyatt Regency Bethesda
Hotel
This is an opportunity for
TMJ patients and their loved ones to come together, share common concerns with
each other and with us, learn more about the activities of The TMJ Association
and how we can improve the plight of all TMJ patients.
TMJ Interagency Working Group Meeting
The TMJ
Interagency Working Group, a coalition of federal agencies whose missions
involve TMJ diseases and disorders, will hold its annual meeting which will
focus on research investigating the complexity of TMJ diseases and disorders
and the overlapping medical conditions which many TMJ patients experience. A panel of scientific experts will be
assembled to stimulate discussion with guest speakers and audience members. TMJA scientific meeting attendees are
cordially invited.
TMJA Scientific Meeting
Evening Reception Ice Cream Social
Hyatt Regency Bethesda Hotel
Meet scientific meeting
participants and attendees at this casual, fun event.
THE THIRD SCIENTIFIC MEETING
OF THE TMJ ASSOCIATION
Advancing Diagnostic Approaches for
TMJ Diseases and Disorders
Hyatt Regency
May 6 -7, 2004
Remarks TBA
Session 1
- TMJ Diseases and Disorders and the Need for Innovative Diagnostic Tools
Christian S. Stohler, D.M.D., Dr.
Med. Dent., University of Maryland Dental School, Baltimore, MD
Moderated by Stephen B. Milam, D.D.S., Ph.D.,
Session
2 Current and Future Methodologies of Imaging for TMJ Diseases and Disorders
(Including X-Ray, MRI, fMRI, PET, NMRI, Ultrasound,
and Thermography Imaging)
Discussion Chair Leaders Thomas F.
Budinger, M.D., Ph.D.,
Tore A. Larheim,
D.D.S., Ph.D.,
Sigvard Kopp, D.D.S., Ph.D.,
James S. Hyde, Ph.D., Medical
Kieran
Murphy, M.D.,
Russell S. Richardson, Ph.D.,
Rudiger Emshoff,
M.D., D.M.D.,
Session
3 Methodologies for Brain Imaging Related to TMJ Diseases and Disorders
Discussion
Chair Leader Ronald Dubner, D.D.S., Ph.D.,
Joel D. Greenspan, Ph.D.,
Robert
C. Coghill, Ph.D.,
Jon-Kar Zubieta,
M.D., Ph.D.,
Session
4 Applications of Nanotechnologies for Imaging and Targeted Joint Therapy
Discussion
Chair Leader Thomas F. Budinger,
M.D., Ph.D.,
Samuel A. Wickline, M.D.,
Thomas F. Budinger, M.D., Ph.D.,
Session
5/Part A: Clinical Research Use of Imaging Technologies for TMJ Diseases and
Disorders
Chair/Discussion Leader Stephen
B. Milam, D.D.S., Ph.D., University of Texas Health Science Center San Antonio,
TX
Tore A. Larheim, D.D.S., Ph.D.,
Jos Dibbets,
D.D.S., Ph.D.,
Carl S. Winalski,
M.D., Brigham and Womens Hospital,
Session
5/Part B: Computational Approaches for
Modeling of TM Joint Mechanics and Morphology Chair/Discussion Leaders Luigi
M. Gallo, P.D.,
Susan W. Herring,
Ph.D.,
William L. Hylander, Ph.D.,
Susan
W. Herring, Ph.D.,
Luigi M. Gallo, P.D.,
Peter Hunter, D. Phil.,
Andrew Pullinger, D.D.S., M.Sc.,
Session
6 Interactions Between Technical and Applied Users
to Develop Recommendations for Diagnostic Criteria for TMJ Diseases and
Disorders
Chair/Moderator
Stephen L. Gordon, Ph.D., Cognate Therapeutics,
1:00 p.m. 3:00 p.m. Development of Recommendations: This session will be divided into two
discussion panels, both with the goal of leading a general discussion aimed at
developing a set of recommendations to the NIH regarding the application of
these technologies in the TMJ research field.
The invited panelists who will lead these discussions will be provided
with abstracts/summaries of presentations prior to the meeting. The panelists in Part A will assess
the current detection limits, technological barriers, and limits of the current
non-evasive imaging technologies and develop a summary document of
recommendations whereby currently available technologies could be immediately
used to establish standardized methods for diagnosis of temporomandibular
diseases and disorders. The panelists in
Part B will address novel investigative approaches that could open up
new avenues of research or be applicable to the development of new or improved
instruments and technologies for use in research and clinical diagnostics, and
preventive strategies. Recommendations will be derived from these discussions regarding
how to move beyond the technological limits of current approaches.
Panel Members:
1.
Stephen
B. Milam, D.D.S., Ph.D. University of Texas Health Science Center, San Antonio,
TX
2.
Stephen
Feinberg, Ph.D., D.D.S. M.S., University of Michigan Medical Center, Ann Arbor,
MI
3.
Sigvard Kopp, D.D.S., Ph.D.,
4.
Randall
Wilk, D.D.S., Ph.D., M.D.,
Panel members:
1.
Ronald
Dubner, D.D.S., Ph.D.,
2.
Stephen
L. Gordon, Ph.D., Cognate Therapeutics,
3.
David
E. Altobelli, D.M.D., M.D., DEKA Research and
Development,